XTalks

AUGUST 2, 2023

is a global pharmaceutical company, working across both developed and emerging markets. Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. It contains the antiviral medications nirmatrelvir and ritonavir. billion the drug generated in 2021. billion in 2022, a 23.43 Pfizer Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Pharma in Brief

DECEMBER 3, 2023

The listed patents must be addressed by the manufacturer of a generic or biosimilar drug before its drug can receive a Notice of Compliance ( NOC ) and be sold in Canada. The early-working exception allows generic or biosimilar manufacturers to work a patented invention “for uses reasonably related” to obtaining regulatory approval.

Regulation 52

Regulation Compliance Medicine Manufacturing 52

The Pharma Data

MAY 15, 2023

Feinglass, MD, MPH was most recently Chief Medical Officer for Life Sciences and Diagnostics and Vice President Global Medical Affairs and Policy, Life Sciences and Diagnostics, at Danaher, a global science and technology company. Our ambition is to be the world’s leading and most valued generics company.

Sales 40

Sales Production Doctors Doctor 40